New dialysis protocol could reduce electrolyte imbalances in ICU kidney patients
NCT ID NCT07514650
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a modified blood-thinning protocol using citrate during continuous kidney replacement therapy in 43 ICU patients with acute kidney injury. The goal is to see if the new method reduces loss of important minerals like potassium and magnesium, cutting down on the need for extra supplements. Researchers will compare the modified approach to standard dialysis techniques.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
regional citrate anticoagulation
What this could lead to
If successful, this could lead to a safer, more efficient way to perform continuous kidney replacement in critically ill patients, reducing the need for electrolyte supplements.
What could go wrong
This is a small, early-stage study (43 participants) focused on protocol validation, not a treatment. Results may not apply to all ICU patients, and the modified protocol may not show clear benefits over standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE KIDNEY INJURY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital de la Santa Creu i Sant Pau
RECRUITINGBarcelona, Barcelona, 08041, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
Contact
Contact
Contact